Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

HRMY

Harmony Biosciences Holdings Inc

Apr 18 • 03:03PM ET

29.35

Dollar change +0.16
Percentage change 0.55	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: CALF IJR VTI VB IWM VXF VBK AVUV IWO IJS

Scroll to Statements

Index	RUT	P/E	13.77	EPS (ttm)	2.13	Insider Own	45.84%	Shs Outstand	56.77M	Perf Week	-6.11%
Market Cap	1.67B	Forward P/E	7.31	EPS next Y	4.02	Insider Trans	-0.05%	Shs Float	30.75M	Perf Month	-9.22%
Income	128.85M	PEG	0.58	EPS next Q	0.62	Inst Own	62.58%	Short Float	20.66%	Perf Quarter	-8.05%
Sales	582.02M	P/S	2.86	EPS this Y	40.55%	Inst Trans	4.47%	Short Ratio	17.64	Perf Half Y	27.00%
Book/sh	8.23	P/B	3.57	EPS next Y	34.18%	ROA	17.35%	Short Interest	6.35M	Perf Year	-11.86%
Cash/sh	6.23	P/C	4.71	EPS next 5Y	23.80%	ROE	29.63%	52W Range	18.61 - 39.26	Perf YTD	-9.13%
Dividend Est.	-	P/FCF	7.61	EPS past 5Y	-	ROI	19.93%	52W High	-25.25%	Beta	0.77
Dividend TTM	-	Quick Ratio	2.72	Sales past 5Y	546.41%	Gross Margin	75.07%	52W Low	57.70%	ATR (14)	1.43
Dividend Ex-Date	-	Current Ratio	2.75	EPS Y/Y TTM	-29.35%	Oper. Margin	32.99%	RSI (14)	41.13	Volatility	5.24% 4.63%
Employees	246	Debt/Eq	0.42	Sales Y/Y TTM	32.93%	Profit Margin	22.14%	Recom	2.00	Target Price	41.62
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-42.57%	Payout	0.00%	Rel Volume	0.71	Prev Close	29.19
Sales Surprise	-0.36%	EPS Surprise	-37.67%	Sales Q/Q	31.26%	Earnings	Apr 30 BMO	Avg Volume	360.26K	Price	29.35
SMA20	-6.95%	SMA50	-8.15%	SMA200	-6.86%	Trades		Volume	221,636	Change	0.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform	$30
Sep-25-23	Downgrade	Goldman	Neutral → Sell	$40 → $31
Sep-07-23	Initiated	Berenberg	Buy	$59
Apr-20-23	Initiated	BofA Securities	Neutral	$35
Oct-14-22	Upgrade	Jefferies	Hold → Buy	$57 → $61
Oct-14-22	Upgrade	Janney	Neutral → Buy	$57 → $61
Aug-03-22	Downgrade	Jefferies	Buy → Hold	$57
Jul-13-22	Downgrade	Goldman	Buy → Neutral	$55
Jul-07-22	Initiated	Mizuho	Buy	$64
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight	$63
Dec-01-21	Initiated	Oppenheimer	Outperform	$55
Nov-04-21	Initiated	Raymond James	Outperform	$58
Sep-23-21	Initiated	Needham	Buy	$57
Mar-29-21	Upgrade	Goldman	Neutral → Buy	$41 → $43
Sep-14-20	Initiated	Piper Sandler	Overweight	$61
Sep-14-20	Initiated	Jefferies	Buy	$51
Sep-14-20	Initiated	Goldman	Neutral	$43

Show Previous Ratings

Apr-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 (PR Newswire)
Apr-11-24 08:05AM	HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST (PR Newswire) +6.44%
Apr-03-24 08:05AM	HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Mar-26-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE (PR Newswire)
Mar-19-24 01:26AM	Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares (GuruFocus.com)
09:38AM	Loading…
Mar-08-24 09:38AM	10 Biotech Stocks with Huge Potential (Insider Monkey)
Feb-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Feb-23-24 11:58AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 11:57PM	Q4 2023 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:30PM	Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript (Motley Fool)
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
07:30AM	Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
Feb-21-24 08:05AM	U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX (PITOLISANT) IN PEDIATRIC NARCOLEPSY (PR Newswire)
Feb-20-24 08:05AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME (PR Newswire)
09:28AM	Loading…
Feb-12-24 09:28AM	The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024 (InvestorPlace)
Feb-08-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024 (PR Newswire) +5.68%
Feb-07-24 12:36PM	The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024 (InvestorPlace)
Jan-23-24 09:55AM	Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade (Zacks)
04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-12-24 09:55AM	Bears are Losing Control Over Harmony Biosciences Holdings, Inc. (HRMY), Here's Why It's a 'Buy' Now (Zacks)
Jan-08-24 08:05AM	HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE (PR Newswire)
Jan-05-24 09:55AM	Does Harmony Biosciences Holdings, Inc. (HRMY) Have the Potential to Rally 32.19% as Wall Street Analysts Expect? (Zacks)
Jan-04-24 12:00PM	All You Need to Know About Harmony Biosciences Holdings, Inc. (HRMY) Rating Upgrade to Buy (Zacks)
Jan-03-24 08:05AM	HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Jan-02-24 06:38PM	Why Harmony Biosciences Stock Got Slammed Today (Motley Fool)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-07-23 08:53PM	Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On (InvestorPlace)
08:05AM	HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
Dec-05-23 01:02PM	16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds (Insider Monkey)
08:05AM	Loading…
08:05AM	HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING (PR Newswire)
Nov-29-23 09:55AM	Wall Street Analysts Predict a 44.38% Upside in Harmony Biosciences Holdings, Inc. (HRMY): Here's What You Should Know (Zacks)
Nov-16-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-15-23 08:05AM	HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500 (PR Newswire)
Nov-13-23 09:55AM	How Much Upside is Left in Harmony Biosciences Holdings, Inc. (HRMY)? Wall Street Analysts Think 76.62% (Zacks)
Nov-08-23 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
08:05AM	HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS (PR Newswire)
Nov-06-23 09:50AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 11:40AM	HRMY vs. REGN: Which Stock Should Value Investors Buy Now? (Zacks) +5.24%
Oct-31-23 06:00PM	Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript (Motley Fool) +19.43%
09:38AM	Harmony Biosciences Holdings Inc (HRMY) Reports Q3 2023 Earnings: 37% YoY Increase in Net Revenue (GuruFocus.com)
08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Lags Q3 Earnings Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-26-23 08:05AM	HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTS (PR Newswire)
Oct-25-23 10:02AM	Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-24-23 10:00AM	Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Expected to Decline (Zacks)
Oct-20-23 12:08PM	12 Cheap Biotech Stocks Smart Investors Are Piling Into (Insider Monkey) -5.54%
Oct-17-23 08:05AM	HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023 (PR Newswire)
Oct-13-23 12:52PM	Why Shares of Harmony Bioscience Are Falling on Friday (Motley Fool) -30.25%
12:11PM	Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall, Friday, 10/13/2023 (Associated Press Finance)
08:00AM	HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA (PR Newswire)
Oct-11-23 08:00AM	HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE (PR Newswire)
Oct-05-23 08:05AM	HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Oct-04-23 09:25AM	2 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Sep-27-23 08:00AM	HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. (PR Newswire)
Sep-25-23 10:41AM	Short seller petitions FDA to reverse approval of Harmony Biosciences drug (American City Business Journals) -8.68%
02:45AM	Nike downgraded amid US wholesale pressures, China risks: 4 big analyst cuts (Investing.com)
Sep-20-23 08:05AM	HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D., NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS (PR Newswire)
Sep-15-23 09:00AM	This Biotech Stock Pick Is Just Starting to Make Beautiful Music (TheStreet.com)
Sep-13-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Sep-09-23 03:59PM	10 Biotech Stocks with Biggest Upside (Insider Monkey)
Sep-07-23 12:12PM	Harmony Biosciences Holdings Inc (HRMY): A Deep Dive into Its Performance Potential (GuruFocus.com)
08:05AM	HARMONY BIOSCIENCES ANNOUNCES US FOOD & DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT FOR TREATMENT OF IDIOPATHIC HYPERSOMNIA (PR Newswire)
Aug-28-23 08:00AM	HARMONY BIOSCIENCES REITERATES CONFIDENCE IN WAKIX® (PITOLISANT) PATENTS FOLLOWING FAVORABLE DECISION BY U.S. PATENT AND TRADEMARK OFFICE (USPTO) TO DENY PETITION FOR REEXAMINATION (PR Newswire) +5.47%
Aug-22-23 08:14AM	11 Most Undervalued Biotech Stocks to Buy According to Analysts (Insider Monkey)
Aug-14-23 11:06AM	Harmony Biosciences to acquire Main Line's Zynerba in up to $200M deal (American City Business Journals)
07:30AM	HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. (PR Newswire)
Aug-03-23 05:56AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-01-23 02:30PM	Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript (Motley Fool)
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Lags Q2 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
07:20AM	HARMONY BIOSCIENCES ANNOUNCES $125 MILLION SHARE REPURCHASE PROGRAM (PR Newswire)
Jul-31-23 11:58PM	15 Worst Performing NASDAQ Stocks In 2023 (Insider Monkey)
Jul-27-23 08:05AM	HARMONY BIOSCIENCES ENTERS INTO $185 MILLION TERM LOAN FACILITY (PR Newswire)
Jul-25-23 08:05AM	Harmony Biosciences Announces Funding for Unique Community Initiatives Through its Patients and Progress at the Heart Awards Programs (PR Newswire)
Jul-20-23 08:05AM	HARMONY BIOSCIENCES ANNOUNCES PLANS TO INITIATE PHASE 3 REGISTRATIONAL STUDY OF PITOLISANT IN PRADER-WILLI SYNDROME FOLLOWING POSITIVE END-OF-PHASE 2 MEETING WITH THE U.S. FOOD AND DRUG ADMINISTRATION (PR Newswire)
Jul-18-23 08:05AM	HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON AUGUST 1, 2023 (PR Newswire)
Jun-29-23 07:00AM	7 Best High-Growth Stocks to Buy if Youre a Young Investor (InvestorPlace)
Jun-22-23 09:30AM	3 Biotech Stocks to Buy With Explosive Upside Potential (InvestorPlace)
Jun-21-23 08:00PM	HRMY: Raising target price to $30.00 (Argus Research)
Jun-12-23 08:30AM	Will Weakness in Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Prove Temporary Given Strong Fundamentals? (Simply Wall St.)
Jun-06-23 08:05AM	HARMONY BIOSCIENCES ANNOUNCES POSITIVE PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PRADER-WILLI SYNDROME AT SLEEP 2023 (PR Newswire)
May-30-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 44th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-25-23 08:05AM	HARMONY BIOSCIENCES COMPLETES ENROLLMENT OF PHASE 3 REGISTRATIONAL INTUNE STUDY IN IDIOPATHIC HYPERSOMNIA (PR Newswire)
May-10-23 08:05AM	HARMONY BIOSCIENCES TO PRESENT NEW WAKIX® (PITOLISANT) SAFETY AND EFFICACY DATA AT SLEEP 2023 ANNUAL MEETING (PR Newswire)
May-03-23 06:19AM	Harmony Biosciences Holdings First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.) +7.27%
May-02-23 02:30PM	Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript (Motley Fool)
08:55AM	Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
May-01-23 08:54PM	3 Strong Buy Stocks With Short Squeeze Potential (TipRanks)
Apr-26-23 08:00PM	HRMY: Lowering target price to $33.00 (Argus Research)
Apr-24-23 08:05AM	HARMONY BIOSCIENCES ANNOUNCES JEFFREY M. DAYNO, M.D. APPOINTED PRESIDENT & CHIEF EXECUTIVE OFFICER (PR Newswire)
Apr-20-23 08:05AM	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS ON MAY 2, 2023 (PR Newswire)
Apr-19-23 02:42PM	Top Biotech Stocks for Q2 2023 (Investopedia)
Apr-16-23 02:01PM	7 Stocks to Buy to Bag Big-Time Returns in Q2 (InvestorPlace)
Apr-12-23 12:35PM	Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months (InvestorPlace)
Apr-09-23 01:19PM	7 Biotech Stocks to Buy for 100% Returns (InvestorPlace)
Apr-03-23 12:36PM	The one-year underlying earnings growth at Harmony Biosciences Holdings (NASDAQ:HRMY) is promising, but the shareholders are still in the red over that time (Simply Wall St.)
Mar-30-23 03:47AM	Harmony Biosciences Holdings, Inc. (HRMY) Soars 8.3%: Is Further Upside Left in the Stock? (Zacks)
Mar-29-23 08:05AM	HARMONY BIOSCIENCES ANNOUNCES ACCELERATED TIMELINE FOR PHASE 3 INTUNE STUDY IN IDIOPATHIC HYPERSOMNIA (PR Newswire) +8.31%

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Mar 29 '24	Option Exercise	0.00	15,000	0	15,000	Apr 02 04:31 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Option Exercise	8.22	11,979	98,467	11,979	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Sale	32.00	11,979	383,328	0	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Option Exercise	8.22	194	1,595	194	Mar 11 05:17 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Sale	32.00	194	6,208	0	Mar 11 05:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRMY

Harmony Biosciences Holdings Inc

Upgrade your FINVIZ experience